cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pear Therapeutics Inc
7 own
11 watching
Current Price
$1.08
$-0.12
(-10%)
logo-pear
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
150.39M
52-Week High
52-Week High
6.74
52-Week Low
52-Week Low
0.9805
Average Volume
Average Volume
0.38M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization150.39M
icon52-Week High6.74
icon52-Week Low0.9805
iconAverage Volume0.38M
iconDividend Yield--
iconP/E Ratio--
What does the Pear Therapeutics Inc do?
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
Read More
News & Events about Pear Therapeutics Inc.
Business Wire
2days ago
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced today the expansion of its collaboration with BrightView Health, an addiction treatment provider that offers evidence-based...
Business Wire
10days ago
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the inclusion of its PDTs reSET and reSET-O on the January 2023 Florida Medicaid Preferred Drug List (PDL). reSET and...
Business Wire
16days ago
The California Department of Health Care Services (DHCS) has selected Pear Therapeutics, Inc. (Nasdaq: PEAR), a leader in developing and commercializing software-based medicines, to support the implementation of the Recovery Incentives: Californias Contingency Management Program. Contingency...
Business Wire
24days ago
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the expansion of its collaboration with Spero Health, an integrated healthcare services organization specializing in local...
Business Wire
2 months ago
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Evercore ISI 5th Annual HealthCONx Conference on Wednesday, November 30, 2022. Corey...
Frequently Asked Questions
Frequently Asked Questions
What is Pear Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Pear Therapeutics Inc shares?
plus_minus_icon
How can I buy Pear Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Pear Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pear Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Pear Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Pear Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pear Therapeutics Inc?
plus_minus_icon
What percentage is Pear Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pear Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.08
$-0.12
(-10%)
logo-pear
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00